Circulating levels of the terminal complement complex are associated with hypercoagulability in patients with stable coronary artery disease. Issue 196 (December 2020)

• Record Type: Journal Article
• Authors: Kluge, Karsten E.; Langseth, Miriam S.; Bratseth, Vibeke; Pettersen, Alf Å.; Arnesen, Harald; Tønnessen, Theis; Seljeflot, Ingebjørg; Helseth, Ragnhild
• Is Part Of: Thrombosis research. Issue 196(2020)
• Page Start: 106
• Page End: 108
• Publication Date: 2020-12
• Subjects: Thrombosis -- Periodicals; 616.135
• DOI: 10.1016/j.thromres.2020.08.023
• Languages: English
• ISSNs: 0049-3848

Abstract

Highlights: Complement and coagulation activation coincide in coronary artery disease (CAD). In CAD, complement activation coincides with endothelial activation and damage. In CAD, complement activation does not coincide with platelet activation. A novel link between immunity and hemostasis in CAD is demonstrated.